Skip to content
healthcare.dev

DOLCE and GABBANA MEET YOUR FLAWLESS MATTE SKIN DUO - EVERLAST PRIMER EVERLAST FOUNDATION

NDC 84003-041, OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE, kit, from DOLCE & GABBANA BEAUTY SRL.

Product NDC
84003-041
Status
Listed
Labeler
DOLCE & GABBANA BEAUTY SRL
Dosage form
KIT
Route
—
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M020
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/84003-041 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

None listed.

Package NDCNDC-11Package
84003-041-01840030041011 KIT in 1 KIT (84003-041-01) * 1 BLISTER PACK in 1 CARTON (84003-044-01) / .6 mL in 1 BLISTER PACK * 1 BLISTER PACK in 1 CARTON (84003-045-01) / .6 mL in 1 BLISTER PACK * 1 BLISTER PACK in 1 CARTON (84003-046-01) / .6 mL in 1 BLISTER PACK * 1 BLISTER PACK in 1 CARTON (84003-043-01) / .6 mL in 1 BLISTER PACK * 1 BLISTER PACK in 1 CARTON (84003-042-01) / .6 mL in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 84003-041 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/84003-041 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 84003-041. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.